Compare DERM & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | PESI |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9M | 208.1M |
| IPO Year | 2021 | 1996 |
| Metric | DERM | PESI |
|---|---|---|
| Price | $7.11 | $13.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 338.9K | 312.5K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.72 | ★ 43.61 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $61,858,000.00 | $642,000.00 |
| Revenue This Year | $39.72 | $34.62 |
| Revenue Next Year | $63.24 | $77.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $8.14 |
| 52 Week High | $9.56 | $16.50 |
| Indicator | DERM | PESI |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 60.92 |
| Support Level | $7.00 | $12.10 |
| Resistance Level | $7.69 | $14.80 |
| Average True Range (ATR) | 0.44 | 1.11 |
| MACD | 0.06 | 0.42 |
| Stochastic Oscillator | 86.21 | 54.91 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.